Featured 13F manager
DME Capital Management David Einhorn
New York, NY 20 processed 13Fs on this site · 2021 Q3–2026 Q2
- $3.9B
- 46 holds
- 2026 Q2
- +22.5% QoQ
- Top 5 38.2%
David Einhorn files DME Capital Management as a Form 13F. The latest book is 2026 Q2 at $3.9B, up 22.5% QoQ, led by Green Brick Partners, Fluor, and Core Natural Resources.
Portfolio
top 5 38.2% · top 10 52.8%
- GRBK - Green Brick Partners 19.4%
- FLR - Fluor 6.2%
- CNR - Core Natural Resources 4.7%
- BHF - Brighthouse Finl 4.6%
- ACHC — 3.3%
- PENN - Penn Entertainment 3.2%
- FBIN - Fortune Brands 3.1%
- PCG - Pg And E 2.9%
- CNC - Centene Del 2.7%
- PKG - Graphic Packaging 2.7%
- SNX - Td Synnex 2.6%
- TEVA - Teva Pharmaceutical Inds 2.5%
- Other 42.1%
AUM over time
Book
| GRBK - Green Brick Partners | Reduce −1.8% | 16,600,508 | $35.06 | $582M | −309,453 | +$172M | |
| CEIXEUR - Consol Energy | Add +49.9% | 2,716,741 | $58.27 | $158M | +904,190 | +$40M | |
| BHF - Brighthouse Finl | Reduce −2.3% | 3,122,743 | $44.11 | $138M | −72,907 | −$26M | |
| KD - Kyndryl | Reduce −5.6% | 8,498,845 | $14.76 | $125M | −507,715 | +$25M | |
| TECK - Teck Resources · CL B | Add +11.4% | 2,491,218 | $36.50 | $91M | +254,700 | +$6M | |
| THC - Tenet Healthcare | Add +116.6% | 1,426,970 | $59.42 | $85M | +768,070 | +$53M | |
| ODP1 - The Odp | Reduce −1.2% | 1,632,140 | $44.98 | $73M | −19,300 | −$2M | |
| GPN - Global Pmts | Add +26.9% | 600,430 | $105.24 | $63M | +127,280 | +$16M | |
| CPRI - Capri | Add +31.6% | 1,244,040 | $47.00 | $58M | +298,740 | +$4M | |
| Black Knight | New | 924,740 | $57.56 | $53M | +924,740 | +$53M | |
| LIVN - Livanova | Add +23.4% | 1,034,896 | $43.58 | $45M | +196,496 | −$1M | |
| Southwestern Energy | Reduce −0.8% | 8,915,700 | $5.00 | $45M | −76,150 | −$8M | |
| GLD - Spdr Gold Tr | Add +8.8% | 227,899 | $183.22 | $42M | +18,358 | +$6M | |
| WFRD - Weatherford Intl | Reduce −0.7% | 579,695 | $59.35 | $34M | −4,030 | +$5M | |
| SLV - Ishares Silver Tr | Reduce −2.4% | 1,487,380 | $22.12 | $33M | −36,630 | −$658K | |
| CIVI - Civitas Resources | Reduce −0.7% | 458,208 | $68.34 | $31M | −3,190 | +$5M | |
| PKG - Graphic Packaging | Hold | 1,067,670 | $25.49 | $27M | — | — | |
| CNXC - Concentrix | Add +116.6% | 207,961 | $121.55 | $25M | +111,940 | +$12M | |
| GPOR - Gulfport Energy | Add +125.5% | 283,000 | $80.00 | $23M | +157,500 | +$13M | |
| FCNCA - First Ctzns Bancshares · CL A | New | 22,550 | $973.10 | $22M | +22,550 | +$22M | |
| NYCBEUR - New York Cmnty Bancorp | New | 2,279,510 | $9.04 | $21M | +2,279,510 | +$21M | |
| GPRO - Gopro · CL A | Reduce −2.5% | 2,597,900 | $5.03 | $13M | −67,240 | −$205K | |
| REZI - Resideo Technologies | Reduce −55.5% | 658,088 | $18.28 | $12M | −819,775 | −$12M | |
| Danimer Scientific · CL A | Add +13.3% | 2,550,000 | $3.45 | $9M | +300,000 | +$5M | |
| Rice Acquisition Ii · CL A | New | 760,000 | $10.24 | $8M | +760,000 | +$8M | |
| LKFT - Galapagos | Reduce −2.6% | 151,368 | $38.64 | $6M | −3,990 | −$1M | |
| Waverley Capital Acquis | Hold | 350,000 | $10.22 | $4M | — | — | |
| Panacea Acquisition Ii · CL A | Hold | 275,000 | $10.22 | $3M | — | — | |
| GANX - Gain Therapeutics | Hold | 546,560 | $4.82 | $3M | — | — | |
| OIH - Vaneck ETF Trust | New | 6,960 | $277.13 | $2M | +6,960 | +$2M | |
| COYA - Coya Therapeutics | Add +0.1% | 392,647 | $3.97 | $2M | +203 | −$299K | |
| IVZ - Invesco Actvely Mngd Etc Fd | New | 96,990 | $14.22 | $1M | +96,990 | +$1M | |
| FCG - First Tr Exchange-Traded Fd | New | 58,540 | $22.52 | $1M | +58,540 | +$1M | |
| Talis Biomedical | Hold | 2,235,783 | $0.4900 | $1M | — | — | |
| Neubase Therapeutics | Hold | 2,727,027 | $0.1850 | $505K | — | — | |
| NUVB - Nuvation Bio · CL A | Hold | 34,995 | $1.66 | $58K | — | — |
Exits / last held
Not current holdings · last reported size, unchanged · gone vs 2022 Q4
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| VSXY - Victorias Secret And | Exit | 0 | $35.78 | $15M | −411,071 | −$15M | |
| Funko · CL A | Exit | 0 | $10.91 | $6M | −521,500 | −$6M | |
| CNX - Cnx Res | Exit | 0 | $16.84 | $4M | −216,165 | −$4M | |
| Finserv Acquisition Ii | Exit | 0 | $10.03 | $3M | −315,000 | −$3M | |
| Polestar Automotive UK | Exit | 0 | $1.12 | $92K | −82,100 | −$92K | |
| 23andme · CLASS A | Exit | 0 | $2.16 | $51K | −23,591 | −$51K |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 46 | $3.9B | +22.5% | 13F-HR | 8/14/2026 | 000117266126003786 |
| 2026 Q1 | 45 | $3.2B | +12.0% | 13F-HR | 5/15/2026 | 000117266126002341 |
| 2025 Q4 | 41 | $2.8B | +12.1% | 13F-HR | 2/17/2026 | 000117266126001122 |
| 2025 Q3 | 37 | $2.5B | +9.3% | 13F-HR | 11/14/2025 | 000117266125005032 |
| 2025 Q2 | 34 | $2.3B | +17.8% | 13F-HR | 8/14/2025 | 000117266125003351 |
| 2025 Q1 | 33 | $2B | +1.5% | 13F-HR | 5/15/2025 | 000117266125002307 |
| 2024 Q4 | 36 | $1.9B | −19.1% | 13F-HR | 2/14/2025 | 000117266125001165 |
| 2024 Q3 | 38 | $2.4B | +17.6% | 13F-HR | 11/14/2024 | 000117266124005240 |
| 2024 Q2 | 39 | $2B | −6.5% | 13F-HR | 8/14/2024 | 000117266124003549 |
| 2024 Q1 | 42 | $2.2B | — | 13F-HR | 5/15/2024 | 000117266124002489 |
| 2023 Q4 | 40 | $2B | +16.3% | 13F-HR | 2/14/2024 | 000117266124001512 |
| 2023 Q3 | 39 | $1.8B | −17.4% | 13F-HR | 11/14/2023 | 000117266123004012 |
| 2023 Q2 | 41 | $2.1B | +15.9% | 13F-HR | 8/14/2023 | 000117266123003174 |
| 2023 Q1 | 39 | $1.8B | +27.4% | 13F-HR | 5/15/2023 | 000117266123002282 |
| 2022 Q4 | 42 | $1.4B | +2.3% | 13F-HR | 2/14/2023 | 000117266123001336 |
| 2022 Q3 | 42 | $1.4B | +9.8% | 13F-HR | 11/14/2022 | 000117266122002565 |
| 2022 Q2 | 47 | $1.3B | −18.3% | 13F-HR | 8/15/2022 | 000117266122002019 |
| 2022 Q1 | 52 | $1.6B | −10.0% | 13F-HR | 5/16/2022 | 000117266122001474 |
| 2021 Q4 | 57 | $1.7B | +17.2% | 13F-HR | 2/14/2022 | 000117266122000884 |
| 2021 Q3 | 58 | $1.5B | — | 13F-HR | 11/15/2021 | 000117266121002370 |
About
DME Capital Management
20 processed 13Fs on this site · 2021 Q3–2026 Q2